Advertisement

Topics

Endometriosis and Brominated Flame Retardant (ENDOTOX Study)

2016-01-11 12:05:13 | BioPortfolio

Published on BioPortfolio: 2016-01-11T12:05:13-0500

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

Validation Study for Endometriosis PRO

Assess the psychometric properties of the Endometriosis Symptom Diary (ESD) and the Endometriosis Impact Scale (EIS) and provide evidence whether the PRO measures are reliable, valid and a...

Characteristics of Patient Population With Endometriosis

The purpose of this study is to collect and analyze data on the characteristics of women who are seeking treatment for endometriosis, suspected endometriosis, pain and/or infertility as pa...

Does Immunotherapy Have a Role in the Management of Endometriosis?

Pathological specimens of 40 women that had been operated for endometriosis will be included in this study. These tissues will be stained with a marker named as PDL-1 in pathological exami...

Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis

Endometriosis can affect quality of life, including physical, psychological and social aspects. It is important to include quality of life measures in evaluating disease severity and respo...

Musculo-scrawny Manifestation Associated With the Endometriosis

The endometriosis is defined by the presence of endometriosic tissue outside of the womb and the prevalence is estimated to be 10% of women.Here is a project aimed to compare musculo-scraw...

PubMed Articles [170 Associated PubMed Articles listed on BioPortfolio]

Systematic review of quality of life measures in patients with endometriosis.

Endometriosis and quality of life has been the subject of much research, however, there is little consensus on how best to evaluate quality of life in endometriosis, resulting in many and diverse scal...

ENDOMETRIOSIS OF THE APPENDIX: WHEN TO PREDICT AND HOW TO MANAGE? MULTIVARIATE ANALYSIS OF 1,935 ENDOMETRIOSIS CASES.

To evaluate appendiceal endometriosis (AE) prevalence and risk factors in endometriotic patients submitted to surgery.

Endometriosis and cancer.

Endometriosis, characterized by the presence of extra-uterine endometrium, is a common gynecologic disorder in reproductive-age women. Although the detailed molecular mechanism of etiology remains une...

Reply to: Adhesion proteins: suitable therapeutic targets or biomarkers of therapy response for endometriosis?

We are pleased to read the recent letter to editor by Barra and Ferrero who have been interested in our recent publication in AOGS. In that report, we demonstrated the decreased expression of Tensin 1...

Is endometriosis associated with irritable bowel syndrome? A cross-sectional study.

Previous studies have found a high prevalence of irritable bowel syndrome (IBS). However, data on this relation in women without bowel endometriosis is limited. The aim of this study was to compare th...

Medical and Biotech [MESH] Definitions

A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.

A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.

A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.

A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS.

A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.

More From BioPortfolio on "Endometriosis and Brominated Flame Retardant (ENDOTOX Study)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial